Peregrine Pharmaceuticals, Inc.( PPHM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Peregrine Pharmaceuticals, Inc.( PPHM)

PPHM 4.220

+0.7%

Jan 5 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: HangTen	9/10/2013 1:23:28 AM
	of 3795

The strategy from Kahuna King is to attract new investors by hyping bavi usage with other therapies. In the conference call summary I read it sounded like they will continue to use bavi in the new studies with other therapies. Bavi is out of date. Its a half-mouse half-human antibody. If the Big Kahuna is serious about positioning bavi in synergy with other therapies to attract real BP interest, he should be preparing to use the fully human version of the antibody. Nobody wants a half-mouse half-human antibody in the 21st century. Easternstar cat got your tongue? Is it true Paul Lytle had some company on that most excellent adventure through Russia you were complaining about? The way I heard it, Paul Steve and a certain female employee were in Switzerland before going to Russia during that summer 2011 business trip. You only complained about Paul.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next